Skip to content

GMO US Value ETF

GMOVNYSE ArcaB

$32.33+0.12 (+0.36%)

As of Oct 13, 2026, 3:59 PM

Intraday session: up, 14 prints from 32.21 to 32.33. Range 32.21 to 32.37. Use the arrow keys to read each point.32.2532.2732.3032.3532.3810 AM12 PM2 PM4 PM
Expense ratio
0.50%
Fund size
$97M
1Y total return
+28.2%
Yield · Last 12 months
1.89%
Holdings
166
Avg volume · 30D
0M sh
NAV per share
$31.95
52W range
low $25.78high $33.47
Launched
Filings
SEC EDGAR

The ETF.net GMOV Grade

B

Score 65 out of 100

Rank
12 of 66
Six-pillar profile for GMOV. Scores out of 100: Cost 59, Risk 81, Mission 59, Tradability 66, Holdings 63, Durability 53. Strongest: Risk (81). Weakest: Durability (53). Leans toward Risk.

Score 65 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    B59 out of 100
    Rank 26 of 66
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    B59 out of 100
    Rank 24 of 27
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A81 out of 100
    Rank 2 of 63
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B66 out of 100
    Rank 12 of 66
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    B63 out of 100
    Rank 28 of 66
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C53 out of 100
    Rank 36 of 66

Our read on GMOV

ETF.net Research

BGMO's quant value playbook in an ETF wrapper: proprietary models and relative valuation analysis picking US stocks, priced below the typical active value fund. Launched in late 2024, so the live record is still short.

Stated mandate

The Fund seeks total return through an actively managed strategy focused primarily on U.S. equities. GMO applies proprietary quantitative methods and relative valuation analysis to select securities it believes have attractive return potential.

Why people hold it

  1. 01Genuinely active, not an index in disguise: GMO uses proprietary quantitative methods and relative valuation to pick US equities it sees as attractively priced.
  2. 02At 0.50%, it undercuts the median fee in its active US value cohort, which is unusual for a boutique manager's first-generation ETF.
  3. 03Sits in the upper half of dozens of active US value ETFs, with one of the milder risk profiles measured in the group.
  4. 04Pays on a quarterly schedule, the standard rhythm for a US equity fund.

Worth knowing

  1. 01Thinly traded and modest in size, so spreads can be wide. Limit orders matter more here than with a mega-fund.
  2. 02Systematic value rivals cost far less: AVLV and SEIV run 0.15%, DFLV 0.21%. You are paying up for human-plus-model stock selection.
  3. 03Live since October 2024, so risk and behavior can only be read off about a year of trading, not a full cycle.

GMOV Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
166
Top-10 weight
33%
Largest holding
MSFT7.7%

Geography

  • United States96.50%
  • Ireland1.59%
  • Switzerland0.96%
  • Bermuda0.53%
  • Sweden0.28%
  • Netherlands0.13%
The fund’s holdings, weight-ordered — page 1 of 12.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001MSFTMicrosoft Corp7.65%13,875$7M815
002METAMeta Platforms Inc Class A5.66%7,645$5M704
003XOMExxonmobil Holdings Corp4.02%23,098$4M511
004JPMJPMorgan Chase & Co2.86%8,320$3M481
005MRKMerck & Co. Inc.2.61%17,369$3M515
006PFEPfizer Inc2.36%81,008$2M378
007VZVerizon Communications Inc2.25%52,507$2M437
008BMYBristol Myers Squibb Co1.98%32,410$2M463
009BACBank of America Corp1.80%32,229$2M439
010PGRProgressive Corp1.69%7,535$2M390
011REGNRegeneron Pharmaceuticals1.65%2,148$2M411
012CIThe Cigna Group1.65%5,659$2M360
013CVXChevron Corp1.54%7,031$1M478
014COFCapital One Financial Corp1.51%7,327$1M353
015PGProcter & Gamble Co/The1.50%9,592$1M428

Showing 1–15 of 166 holdings

GMOV Performance

Launched Oct 28, 2024

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
GMOV$12,820
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. GMOV $12,820. SPY $12,044. Use the arrow keys to read each point.$9,493$11,469$13,444Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for GMOV. Periods over one year show the average yearly return.
PeriodGMOV
Year to date+19.0%
1 month−1.3%
3 months+5.4%
1 year+28.2%
3 yearsFund is under 3 years oldper year—
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for GMOV
YearReturn barGMOV
2026 YTD+19.0%
2025+14.8%
2024−1.3%

History from Oct 29, 2024

GMOV in the news

Filtered to GMOV · US Active Value

GMOV Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
1.89%Last 12 months
Payout per share
$0.61Last 12 months
Last payment
$0.17 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2024–2026

One bar per payment. 8 payments from 2024 to 2026 YTD. Dec 30, 2024 $0.07; Mar 31, 2025 $0.10; Jul 1, 2025 $0.15; Sep 30, 2025 $0.15; Dec 30, 2025 $0.14; Mar 31, 2026 $0.17; Jun 30, 2026 $0.13; Sep 30, 2026 $0.17. Use the arrow keys to read each point.202420252026YTD
Ex-datePay dateAmount per share
Sep 30, 2026Oct 1, 2026$0.17
Jun 30, 2026Jul 1, 2026$0.13
Mar 31, 2026Apr 1, 2026$0.17
Dec 30, 2025Dec 31, 2025$0.14
Sep 30, 2025Oct 1, 2025$0.15
Jul 1, 2025Jul 2, 2025$0.15
Mar 31, 2025Apr 1, 2025$0.10
Dec 30, 2024Dec 31, 2024$0.07

GMOV Risk

How much the fund’s monthly returns vary, scaled to a year.
12.6%
Annualised · 23 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.95
vs 3-month T-bills · 23 months to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−16.7%
23 months · trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.65
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

GMOV Cost

Expense ratio0.50%
  • The middle half of US Active Value funds
  • Median 0.55%

26 of the 66 US Active Value funds charge less.

GMOV costs $50.00 a year on $10,000. The median US Active Value fund costs $55.00.

Other funds in US Active Value